Evonik Acquires Transferra Nanosciences
Evonik will acquire Transferra for an undisclosed amount, and the transaction is scheduled to close at the end of July 2016
Evonik, a German creative industrial group focused on specialty chemicals, announced on June 28, 2016 that it has acquired Transferra Nanosciences, a biotechnology company based in Canada, for an undisclosed amount, the company said in a press announcement. According to Evonik, the transaction is scheduled to close at the end of July 2016. The acquisition allows Evonik to further expand the portfolio of its Business Line Heath Care in the area of parenteral drug delivery technologies and services.
Transferra is a contract development and manufacturing organization (CDMO) that services biotechnology companies developing pharmaceutical products. Transferra services include prototype identification, scale-up and process development, analytical support and qualification of methods, production of test articles for toxicology studies, and cGMP manufacturing of clinical trial materials. Evonik Health Care is a provider of formulation development and GMP manufacturing services to the pharmaceutical industries for advanced parenteral drug depot formulations.
Source: Evonik
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
